z-logo
open-access-imgOpen Access
Follicle-Stimulating Hormone (FSH) Levels During Androgen Deprivation Therapy Are Not Associated With Survival or Development of Castration-Resistant Prostate Cancer
Author(s) -
Kaleem Atchia,
FranceHélène Joncas,
Lily Summers Trasiewicz,
Wei Phin Tan,
Keyue Ding,
Brant A. Inman,
Paul Torren
Publication year - 2022
Publication title -
société internationale d’urologie journal
Language(s) - English
Resource type - Journals
ISSN - 2563-6499
DOI - 10.48083/lwhq7760
Subject(s) - prostate cancer , medicine , androgen deprivation therapy , follicle stimulating hormone , oncology , androgen , hormone , gonadotropin , endocrinology , cancer , luteinizing hormone

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom